Author/Authors :
Ghori, Masood Ayyub Sheikh Khalifa Medical City - Cardiac Science Department, United Arab Emirates , Bakir, Sherif Sheikh Khalifa Medical City - Cardiac Science Department, United Arab Emirates , Ellahham, Samer Sheikh Khalifa Medical City - Department of Cardiac Sciences, Quality Division, United Arab Emirates , Al Nassir, Adnan Sheikh Khalifa Medical City - Cardiac Science Department, United Arab Emirates , Al Zubaidi, Abdulmajeed Sheikh Khalifa Medical City - Cardiac Science Department, United Arab Emirates , Augustin, Norbert Sheikh Khalifa Medical City - Cardiac Science Department, United Arab Emirates , Abdelaziz, Moataz Ayman Sheikh Khalifa Medical City - Cardiac Science Department, United Arab Emirates , Turrin, Nicolas Patrick Sheikh Khalifa Medical City - Quality Division, United Arab Emirates , Al Mahmeed, Wael Abdulrahman Sheikh Khalifa Medical City - Cardiac Science Department, United Arab Emirates
Abstract :
In the few reported cases of prosthetic mitral valve thrombosis, where surgical intervention was considered as high risk, fibrinolytic therapy had proved life saving. The authors present clinical, laboratory, and imaging data from such a patient, with prosthetic mitral valve thrombosis and its successful management with tenecteplase. The use of tenecteplase as a viable fibrinolytic agent for the first time was justified, due to the lack of immunogenicity concerns compared to streptokinase.
